Rifampin recalls
The FDA has published 21 recalls involving Rifampin since 2014. The latest was reported on 17 Apr 2024. Most were for potency & assay. Akorn has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls 21 since 2014
Last 12 months 0 reported
Class I 0 0% of total
Ongoing 4 latest 17 Apr 2024
Recalls per month, last 24 months click a bar for that month Severity split
0 0%19 90%2 10%
Ongoing rifampin recalls 4 active
All rifampin recalls, newest first 21 total Reported Class Recall Company Reason Where 17 Apr 2024 Drug CLASS II Rifampin Capsules USP, 300mg recalled by Lupin Pharmaceuticals Lupin Pharmaceuticals Potency & Assay Nationwide 7 Feb 2024 Drug CLASS II Rifampin Capsules USP 300mg recalled by Lupin Pharmaceuticals Rifampin Lupin Pharmaceuticals Potency & Assay MD 7 Feb 2024 Drug CLASS II Rifampin Capsules USP, 150 mg doses recalled Amerisource Health Services Potency & Assay Nationwide 7 Feb 2024 Drug CLASS II Rifampin Capsules USP 150mg recalled by Lupin Pharmaceuticals Rifampin Lupin Pharmaceuticals Potency & Assay MD 7 Jun 2023 Drug CLASS II Rifampin Capsules USP, 150 mg recalled by Akorn Akorn Potency & Assay Nationwide 7 Jun 2023 Drug CLASS II Rifampin Capsules USP, 300 mg recalled by Akorn Akorn Potency & Assay Nationwide 25 Jan 2023 Drug CLASS II Rifampin Capsules USP, 300 mg (10 recalled Amerisource Health Services Potency & Assay Nationwide 18 Jan 2023 Drug CLASS II Rifampin Capsules USP, 300 mg recalled by Lupin Pharmaceuticals Rifampin Lupin Pharmaceuticals Potency & Assay Nationwide 18 Jan 2023 Drug CLASS II Rifampin Capsules, 300 mg blister card recalled by RemedyRepack RemedyRepack Potency & Assay PA 26 Oct 2022 Drug CLASS II Rifampin Capsules, USP, 300 mg recalled by Golden State Medical Supply Golden State Medical Supply Nitrosamine Impurity Nationwide 26 Oct 2022 Drug CLASS II Rifampin Capsules, USP, 150 mg recalled by Golden State Medical Supply Golden State Medical Supply Nitrosamine Impurity Nationwide 5 Oct 2022 Drug CLASS II Rifampin Capsules, USP, 300 mg, a) bottle recalled by Akorn Akorn Nitrosamine Impurity Nationwide 5 Oct 2022 Drug CLASS II Rifampin Capsules, USP, 150 mg recalled by Akorn Akorn Nitrosamine Impurity Nationwide 24 Aug 2022 Drug CLASS II Rifampin Capsules, USP, 150 mg HDPE recalled by Lupin Pharmaceuticals Rifampin Lupin Pharmaceuticals Nitrosamine Impurity Nationwide 27 Apr 2022 Drug CLASS II Rifampin for Injection, USP, 600 mg/vial, One Vial recalled Rifampin Mylan Pharmaceuticals Potency & Assay Nationwide 16 Oct 2019 Drug CLASS II Rifampin for Injection, USP, 600 mg/vial recalled Rifampin Mylan Laboratories Limited (Sterile Products Division) Potency & Assay Nationwide 25 Nov 2015 Drug CLASS III Rifampin For Injection USP, 600 mg*/vial recalled by Akorn Akorn Potency & Assay Nationwide 22 Jul 2015 Drug CLASS II Rifampin for Injection, USP 600mg/vial in a vial recalled Rifampin Fresenius Kabi USA Potency & Assay Nationwide 20 May 2015 Drug CLASS II Rifampin 25 mg/ Susp, Health Innov Pharmacy recalled Health Innovations Pharmacy Sterility NC 25 Mar 2015 Drug CLASS II Rifampin for Injection,USP, 600 mg per vial recalled Heritage Pharmaceuticals Sterility Nationwide 1 Oct 2014 Drug CLASS III Rifampin for Injection USP, 600 mg*/vial (Sterile) recalled by Akorn Akorn Potency & Assay Nationwide
Should you stop taking Rifampin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.